The transfection technologies market will show a rapid growth due to the rising incidences of cancer and the increase in research & development in the field of cell based therapies.
As there is increasing prevalence of cancer and growing number of the obese population, there is a rising demand for transfection. This factor is driving the transfection technologies market. In addition, initiatives taken by various government organizations further accentuates the growth of this market. However, the high cost of instruments may restrain the overall market growth in the years to come.
Key Market Trends
Reagent-based Method is Showing Significant Growth in the Transfection Technologies Market
Reagent based transfection technology market is experiencing significant growth owing to cost effectiveness and less complicated methods involved during transfection. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection. Instrument-based methods are also less time consuming and accurate and all these advantages drives the growth of this segment.
North America is Found Leading the Transfection Technologies Market
North America is found dominating the market, that is driven by factors such as increasing cases of infectious diseases demanding the need of antibiotics and the growing use of cell-based products which require transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases. The United States and Canada are the major consumers of transfection technologies in this region.
Asia Pacific is also estimated to grow at the highest CAGR, as the developing countries like India and China are the major consumers of transfection technologies in this region.
The global transfection technologies market is concentrated with international and regional companies that offer products for different types of transfection methods for pharmaceutical and biotechnology companies, contract research organizations (CRO), and academic and research institutes.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Cancer
4.2.2 Increase in Research & Development in the Field of Cell Based Therapies
4.3 Market Restraints
4.3.1 High Cost of Transfection Technology Instruments
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Method
5.1.1 Reagent-based Method
5.1.2 Instrument-based Method
5.2 By Application
5.2.1 Biomedical Research
5.2.2 Therapeutic Delivery
5.2.3 Protein Production
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle-East and Africa
5.3.5 South America
18.104.22.168 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Lonza Group
6.1.2 Bio-Rad Laboratories, Inc.
6.1.3 Thermo Fisher Scientific
6.1.4 Qiagen NV
6.1.5 Promega Corporation
6.1.6 SignaGen Laboratories
6.1.7 Merck KGaA
6.1.8 Altogen Biosystems
6.1.9 Polyplus-transfection SA
6.1.10 Mirus Bio
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.